Brief: Balaxi Pharmaceuticals Re-Appoints Ashish Maheshwari As MD
25/04/2022 11:03
April 25 (Reuters) - Balaxi Pharmaceuticals Ltd BALX.NS :
* BALAXI PHARMACEUTICALS - APPROVED RE-APPOINTMENT OF ASHISH MAHESHWARI AS MD
Further company coverage: BALX.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Balaxi Pharmaceuticals
See all newsBrief: Balaxi Pharmaceuticals Received WHO-GMP Certification For Jadcherla Facility
India's Balaxi Pharma up after Africa, Latam expansion
Brief: Balaxi Pharmaceuticals Expands Global Reach With Hospital Partnerships In Angola
Brief: Balaxi Pharmaceuticals To Set Up Pharmaceutical Formulation Plant In A Phased Manner
Brief: Balaxi Pharmaceuticals Approves Set Up Of First Pharmaceutical Formulation Plant At Jadcherla, Hyderabad